INTENSITY THERAPEUTICS INC
For the period ended Sep 30, 2024. Filed Nov 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 13, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Intensity Therapeutics, Inc. | ||
| Date: November 13, 2024 | By: | /s/ Lewis H. Bender |
|---|---|---|
| Lewis H. Bender | ||
| President, Chief Executive Officer and Chairman | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Lewis H. Bender | President, Chief Executive Officer and Chairman | November 13, 2024 |
| Lewis H. Bender | (principal executive officer) | |
| /s/ Joseph Talamo | Chief Financial Officer | November 13, 2024 |
| Joseph Talamo | (principal financial officer) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.